期刊文献+

原发性高血压伴舒张功能不全患者血浆脑利钠肽水平的相关临床研究

下载PDF
导出
摘要 目的探讨血浆脑利钠肽的测定在评价原发性高血压伴舒张功能不全患者中的价值。方法将118例临床诊断为原发性高血压的患者,按是否存在单纯舒张功能不全,分为舒张功能不全组(n=60)和心功能正常组(n=58),另选30例健康志愿者作为对照组,分别测定三组的BNP浓度进行对比。结果舒张功能不全组的BNP浓度显著高于心功能正常组和对照组,而心功能正常组和对照组间差异无显著性。以105ng/L为标准,诊断原发性高血压合并舒张功能不全的敏感性为85%,特异性为86.2%。结论血浆BNP水平是评价原发性高血压伴舒张功能不全的敏感指标,对其临床诊断和治疗有一定的价值。
出处 《中国医刊》 CAS 2011年第3期43-44,共2页 Chinese Journal of Medicine
  • 相关文献

参考文献6

  • 1Cowie MR Jourdain P, Maisel A, et al. Clinical application of B-type natriuretic peptide testing [J]. Eu Hert J,2003,24(19):1710-1718.
  • 2胡咏梅,王勉,赵思勤,李秋,聂晓莉,吴涛,刘小蓉,张文勇.B型利钠肽和肺毛细血管嵌压对心力衰竭远期心脏事件的预测价值[J].中华心血管病杂志,2008,36(9):786-789. 被引量:18
  • 3Suzuki M, Yamamoto K, Watanabe S, et al. Association between elevated brain natriuretic peptide levels and the development of left ventricular hypertrophy in patients with hypertension [J]. Am J Med,2000,108(8):627-633.
  • 4Kohno M, Horio T, Yokokawa K, et al. Brain natriuretie peptide as a marker for hypertensive left ventricular hypertrophy: changes dur-ing 1-year anti-hypertensive therapy with angiotension-eoverting-en-zyme inhibitor [J]. Am J Med,1995,98:257-265.
  • 5Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natri-uretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings [J]. Circulation,2002,105: 595-601.
  • 6Krishnaswamy P, Lubien E, Clopton P, et al. Utility of B-natriuret-ic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction[J]. Am J Med.2001,111:274-279.

二级参考文献10

  • 1赵思勤,李秋,吴涛,刘小蓉,赵宁,聂晓莉,王勉,胡咏梅.心力衰竭患者脑利钠肽浓度与血流动力学的关系及临床意义[J].中华心血管病杂志,2005,33(6):502-504. 被引量:40
  • 2Macintyre L, Capewell S, Steward S, et al. Evidence of improving prognosis in heart failure: trends in case fatality in 66547 patients hospitalized between 1986 and 1995. Circulation, 2000, 102: 1126-1131.
  • 3Groenning BA, Nilsson JC, Sondergard L, et al. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. Eur J Heart Fail, 2001, 3:699-708.
  • 4Betteneourt P, Ferreira A, Dias P. Predictors of prognosis in patients with stable mild to moderate heart failure. J Card Fail,2000, 6: 306-313.
  • 5Kazanegra R, Cheng V, Garcia A, et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressure in patients treated for decompensated heart failure : a pilot study. J Card Fail, 2001,7:21-29.
  • 6Cheng V, Kazanagra R, Garcia A, et al. A rapid bedside test for B-type peptides predicts treatment outcomes in patients admitted for decompensated heart failure : a pilot study. J Am Coll Cardiol, 2001, 37:386-391.
  • 7Shah MR, Stinnett SS, McNulty SE, et al. Hemodynamics as surrogate end points for survival in advanced heart failure: an analysis from FIRST. Am Heart J, 2001, 141 : 908-914.
  • 8Alehagen U, Lindstedt G, Levin LA, et al. Risk of cardiovascular death in elderly patients with possible heart failure. B-type natriuretic peptides (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6-year follow-up pf a primary care population. International .loumal of Carfiology, 2005, 100: 125-133.
  • 9Mc Donagh T, Cunningham AD, Morrison CE, et al. Left ventricular dysfunction, natriuretic peptide, and mortality in an urban population. Heart, 2001, 86: 21-26.
  • 10Yu CM, Sanderson JE. Plasma brain batriuretic peptide: an independent predictor of cardiovascular mortality in acute heart failure. Eur J Heart, 1999, 1 : 59-65.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部